CompletedNCT02229903
An Evaluation of the Safety and Efficacy of the dTMS Treatment for OCD
Device studyAges 22–68Multiple countries
Understand this study
Who was this study for?
Listed age limits: 22 years to 68 years.
- Listed locations
- Los Angeles and 11 more locationsSee all locations and recruitment
Study information
Study start dateSeptember 2014
- Recruitment status
- Completed
- Enrollment listed in the registry
- 100
- Sponsor
- Brainsway
- Sponsor type
- Unknown or unclear
- Study type
- Device
- Intervention type
- DEVICE
- Study phase
- Not clearly listed
- Locations
- United States, Canada, Israel
- Age range
- From 22 Years to 68 Years
- Official registry ID
- NCT02229903
- Official title
Show the full official title
A Prospective Double Blind Randomized Controlled Trial to Evaluate the Safety and Efficacy of the Deep Transcranial Magnetic Stimulation (dTMS) in Obsessive-Compulsive Subjects
Get this study by email
Recruitment & locations
CompletedLos Angeles, United States · San Diego, United States · Gainesville, United States
7 more locations
- Juno Beach, United States
- Royal Palm Beach, United States
- Chicago, United States
- New York, United States
- Mason, United States
- Toronto, Canada
- Tel HaShomer, Israel
Questions about this study
Who is behind this study?
The study sponsor is Brainsway.
Who was this study for?
Listed age limits: 22 years to 68 years.
